Corneal cross-linking trial for keratoconus eye
Part of Eyes & vision clinical trials.
This trial tests how safe and effective corneal cross-linking is for people with keratoconus, a condition that changes the shape of the clear front surface of the eye. If you qualify, the study will also require several follow-up visits to check your eye health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a written informed consent form
- You have keratoconus diagnosed
- You can keep your gaze steady enough for the eye testing during the study
- You can follow all study instructions and come to follow-up visits as scheduled
- You do not have a known allergy or sensitivity to the treatment or its ingredients
- Your study eye does not have other eye diseases that could raise risk for future complications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if placing a special freeze-dried amniotic membrane on the eye after crosslinking surgery helps improve healing and comfort for people with progressive keratoconus, a condition where the cornea thins and bulges.
This trial tests a new combined treatment for keratoconus that includes both a surface laser (phototherapeutic keratectomy) and corneal collagen crosslinking (CXL). It may help strengthen your cornea and improve vision.
This study compares two types of corneal cross-linking to treat keratoconus, a condition that makes the front of the eye bulge. The goal is to find which method works better to stop the disease from getting worse.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This Phase 1 study tests whether a specific corneal cross-linking system (called PXL-Platinum 330) is safe and effective for people with progressive keratoconus, a condition that makes the cornea thin and bulge. The goal is to slow vision changes and see how well the treatment works in the short term.
This study tests a same-day procedure that strengthens the cornea (the clear front part of the eye) in both eyes using a special light treatment, called cross-linking. It may help slow or stop the progression of keratoconus, a condition where the cornea becomes cone-shaped and causes blurry vision.
Hear when a new Progressive Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.